Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

R. Loomba , V. Seguritan , W. Li (1) , T. Long , N. Klitgord , A. Bhatt , P. S. Dulai , C. Caussy (2) , R. Bettencourt (3) , S. K. Highlander , M. B. Jones , C. B. Sirlin , B. Schnabl , L. Brinkac , N. Schork , C. H. Chen (4) , D. A. Brenner (5) , W. Biggs , S. Yooseph , J. C. Venter (6) , K. E. Nelson

1 CFD Lab [Montréal]
2 CarMeN - Cardiovasculaire, métabolisme, diabétologie et nutrition
3 UC San Diego NAFLD Research Center
4 Dept Anim Ind, Livestock Ind Sect
5 Department of Medicine
6 CRA - Celera Genomics

Domaines: Sciences du Vivant [q-bio]

R. Loomba, V. Seguritan, W. Li, T. Long, N. Klitgord, et al.. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. CELL METABOLISM, 2019, 30 (3), pp.607. ⟨10.1016/j.cmet.2019.08.002⟩. ⟨hal-02466197⟩